Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KYMR

Kymera Therapeutics Inc

May 29 • 04:00PM ET

81.42

-0.04 -0.05 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN INCY KRYS NUVL AXSM CYTK MDGL VKTX KROS NBIX

| Held by: VTI VB IWM XBI VBK VXF IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.57	Insider Own	13.55%	Shs Outstand	82.18M	Perf Week	1.00%
Market Cap	6.70B	Forward P/E	-	EPS next Y	-4.30	Insider Trans	11.46%	Shs Float	71.13M	Perf Month	-0.11%
Enterprise Value	6.13B	PEG	-	EPS next Q	-0.73	Inst Own	105.51%	Short Float	14.06%	Perf Quarter	-10.87%
Income	-315.00M	P/S	130.10	EPS this Y	5.11%	Inst Trans	8.09%	Short Ratio	17.29	Perf Half Y	23.29%
Sales	51.48M	P/B	4.35	EPS next Y	-22.81%	ROA	-24.35%	Short Interest	10.00M	Perf YTD	4.64%
Book/sh	18.73	P/C	10.29	EPS next 5Y	-8.38%	ROE	-27.09%	52W High	103.00 -20.95%	Perf Year	169.16%
Cash/sh	7.91	P/FCF	-	EPS past 3/5Y	-8.68% -3.19%	ROIC	-19.61%	52W Low	28.50 185.68%	Perf 3Y	176.75%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-5.74% 2.87%	Gross Margin	83.90%	Volatility	2.91% 4.12%	Perf 5Y	69.31%
Dividend TTM	-	EV/Sales	119.02	EPS Y/Y TTM	-15.21%	Oper. Margin	-690.19%	ATR (14)	3.16	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.81	Sales Y/Y TTM	-12.58%	Profit Margin	-611.96%	RSI (14)	47.11	Recom	1.04
Dividend Gr. 3/5Y	- -	Current Ratio	10.81	EPS Q/Q	13.26%	SMA20	-1.14%	Beta	2.03	Target Price	118.27
Payout	-	Debt/Eq	0.05	Sales Q/Q	55.50%	SMA50	-2.29%	Rel Volume	1.01	Prev Close	81.46
Employees	238	LT Debt/Eq	0.04	Earnings	Apr 30 BMO	SMA200	14.85%	Avg Volume	578.68K	Price	81.42
IPO	Aug 21, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	19.36% 315.71%	Trades		Volume	586,765	Change	-0.05%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)